Technology | October 28, 2008

Nemoto Kyorindo Contrast Injector Tailors Protocals to Patient

Nemoto Kyorindo's GE-Nemoto Dual Shot Alpha, which features Body Weight Protocol (BWP), Linear Decay Protocol (LDP) and Dilution Phase Protocol. The BWP method tailors the protocol based on the patients weight and the contrast concentration. The LDP uses less contrast to deliver the same amount of enhancement, injection time and image quality as normal injector methods, said the company. The Dilution Phase Protocol delivers contrast and saline simultaneously, which is commonly used in cardiac imaging today.

Related Content

Collaboration includes robust education and training to support radiologists and imaging specialists
News | Mammography
Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
The latest MyBreastAI Suite supports clinicians in accelerating breast cancer detection, while the company’s Pristina Bright solution helps healthcare providers start a new contrast program
News | Mammography
GE HealthCare to feature Mobile Mammography Screening Truck along with Latest AI Platform as part of SBI2024 Breast Cancer Imaging Showcase

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
VUEWAY (gadopiclenol) solution for injection and VUEWAY (gadopiclenol) Pharmacy Bulk Package are available for use in the U.S. following the market launch in February 20231
News | Contrast Media
American College of Radiology Classifies VUEWAY as a Group II Agent Relative to NSF

May 16, 2023 — Bracco Imaging, an innovative world leader delivering end-to-end products and solutions through a ...

Time May 16, 2023
arrow
In the past year, the radiology community has been a first-hand, hands-on witness to myriad unexpected challenges and unprecedented partnerships emerging on the scene of the contrast media market
Feature | Contrast Media | By Christine Book
A Look Inside the Contrast Media Market

In the past year, the radiology community has been a first-hand, hands-on witness to myriad unexpected challenges and ...

Time May 03, 2023
arrow
Sponsored Content | Videos | Contrast Media
VIDEO: Talking Trends with Bracco: Investing in the Future of Radiology

Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...

Time February 27, 2023
arrow
First dosage administered at the Hospital of the University of Pennsylvania following FDA approval
News | Contrast Media
Guerbet Announces Commercial Launch and First Patient Dosing of Elucirem (Gadopiclenol) Injection

February 16, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced ...

Time February 16, 2023
arrow
While the global COVID-19 pandemic took its toll on imaging diagnostics, the market for contrast agent injector systems is poised for significant growth for a range of reasons.
Feature | Contrast Media Injectors | By Christine Book
Contrast Media Injectors: Market Outlook and Opportunities

The vital, and growing role of contrast media, and the medical devices employed to inject the agent into the body ...

Time January 19, 2023
arrow
GE Healthcare will offer its own brand CT Motion injector, an innovative, multi-dose, syringeless technology developed and manufactured by ulrich medical, to a growing injector market in the U.S.
News | Computed Tomography (CT)
GE Healthcare and ulrich medical announce an Agreement to Offer a Branded Multi-dose Contrast Media Injector in the U.S.

December 12, 2022 — GE Healthcare announced an agreement with ulrich medical for a GE Healthcare branded contrast media ...

Time December 12, 2022
arrow
Bracco Diagnostics Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved Gadopiclenol Injection, a new, highly stable macrocyclic gadolinium-based contrast agent (GBCA), in partnership with Guerbet.. 
News | Contrast Media
Bracco and Guerbet Partner to Expand Access to Novel Imaging Agent

Editor’s note: On September 21, 2022, both Guerbet and Bracco Diagnostics released news detailing the FDA approval of a ...

Time September 22, 2022
arrow
EHR screenshot showing sidebar text displayed to referring clinicians after placing orders for body CT (neck, chest, or abdomen and pelvis), describing iohexol shortage and providing appropriate strategies for iodinated contrast media conservation.
News | Contrast Media
EHR Interventions for Contrast Media Shortage Impact CT Utilization

August 3, 2022 — According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), electronic health ...

Time August 03, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now